Department of Biostatistics

June 2, 2022

Sex & race & door-to-ECG time

More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.

By Paul Govern
March 31, 2022

Black patients with cancer face worse COVID outcomes: study

Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

By Tom Wilemon
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt’s Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

By Tom Wilemon
January 31, 2022

Impact of digital health interventions

Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.

By Leigh MacMillan
January 14, 2022

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.

By Tom Wilemon
From left, Dandan Liu, PhD, Alan Storrow, MD, and Sunil Kripalani, MD, MSc, are testing the real-world implementation of a risk stratification tool to avoid unnecessary hospital admissions of patients diagnosed with acute heart failure in the emergency department.
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

By Bill Snyder
November 11, 2021

VUMC tests drugs for COVID outpatient treatment

By Paul Govern
September 9, 2021

Raman, Balucan receive health equity research grants

Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.
By Craig Boerner
July 27, 2021

Prediction models for breast cancer

Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction.
By Leigh MacMillan
April 15, 2021

Method proposed to correct misinterpretations of long-term survival rates for immunotherapies

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.
By Tom Wilemon
April 1, 2021

Study outlines VUMC’s strategy for a learning health care system

New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.
By Paul Govern
December 15, 2020

A deeper look at out-of-home care

Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report.
By Bill Snyder
October 30, 2020

VUMC mourns loss of Biostatistics pioneer Federspiel

Charles Foster (Chuck) Federspiel, PhD, a beloved member of the Vanderbilt University faculty for 61 years and founding director of the Division of Biostatistics, died on Oct. 19. He was 91.
By Bill Snyder
1 2 3 4 5 … 7